At Zenovel, our team is responsible for transforming integrated biologics support by offering a comprehensive framework that facilitates the transition of biologic innovations from initial discovery to market launch, assisting biotech and pharmaceutical companies in navigating complexities with confidence.
Understanding Biologics in Therapeutics
Biologics are a transformative aspect of modern medicine, consisting of large, complex molecules derived from living cells, including therapeutic proteins, monoclonal antibodies, vaccines, cell and gene therapies, and recombinant proteins. Unlike conventional small molecules, which are chemically synthesized and simpler, biologics’ structures are more intricate and sensitive to manufacturing conditions. Their heterogeneity necessitates advanced analytical methods to guarantee consistency, potency, and safety in their production.
The regulatory pathway for biologics is influenced by their molecular complexity. Most are overseen by the FDA’s Center for Biologics Evaluation and Research (CBER), which regulates vaccines, allergenics, blood components, and gene therapies. Market entry typically involves a Biologics License Application (BLA), requiring thorough evidence of safety, purity, and potency. The FDA has recently implemented more flexible, risk-based CMC approaches for cell and gene therapies to lower barriers while maintaining quality standards.
The Global Biologics Market: A Landscape of Unprecedented Growth
The global biologics market, valued at around $412 billion in 2025, is expected to grow significantly, reaching nearly $744 billion by 2031 at a CAGR exceeding 10%. Other estimates suggest it might exceed $820 billion by 2035, driven by demand for targeted therapies and rising healthcare costs. Biologics are crucial to the future of medicine, with the global pharmaceutical industry projected to reach approximately $1.72 trillion in 2026.
Zenovel’s Comprehensive Biology Services
At Zenovel, we offer a comprehensive suite of biology services that encompass the complete biologic development lifecycle, from target identification through to regulatory submission. Their capabilities aim to expedite timelines, minimize risks, and uphold high standards of quality and compliance
Early-Stage Discovery & Molecular Biology Research
Our biology services support drug development by providing molecular biology research, biological assays, and in vitro testing. We assist pharmaceutical companies in accelerating drug discovery and producing reliable biological data, ensuring that early evaluations meet regulatory expectations. By incorporating discovery expertise from the start, we help de-risk pipelines and identify promising candidates for development.
Cell-Based Assays & In Vitro Pharmacology
Understanding the interaction of biologics with biological systems is crucial. Our team develops and validates cell-based assays utilizing various cell lines and primary cells, focusing on diverse signaling pathways and therapeutic approaches. These assays support evaluations of potency, cellular binding, and disease-specific biomarkers, providing reproducible data essential for decision-making from discovery to cGMP testing. We emphasize appropriate cell line selection, disease relevance, and signaling pathways to ensure our assays are scientifically robust and clinically impactful.
Preclinical Development & IND-Enabling Studies
Advancing a biologic into clinical trials necessitates strong preclinical data. Our services comprise pharmacokinetics analysis, immunogenicity testing, and IND-enabling studies crucial for regulatory submissions. We aid in developing biologics, including ADCs, cell and gene therapies, and RNA-based therapeutics, ensuring the generation of required safety and pharmacology data. Our GLP-compliant toxicology and bioanalytic studies support successful Investigational New Drug applications, facilitating first-in-human trials.
Clinical Trial Management & Full-Service Execution
We provide comprehensive services for biologic clinical trials, including planning, project management, site management, and monitoring. We address the operational challenges specific to biologic trials, focusing on patient recruitment, retention, and managing complex protocols. Our integrated approach enhances the trial process, ensuring timelines are adhered to and data integrity is preserved throughout.
Regulatory Strategy & Biologics Registration
We offer specialized biologics registration services to facilitate compliance with U.S. and EU regulations, focusing on the approval process for biologics. Our regulatory experts assist in preparing and submitting comprehensive documentation for Biologics License Applications (BLAs) and managing agency inquiries and pre-approval inspections. Additionally, we provide post-submission regulatory services to help manufacturers maintain compliance and monitor product performance following market authorization.
GMP Batch Release & Quality Control
Consistency and quality are essential for biologic products. Zenovel offers GMP-certified importation, batch testing, and batch release services for human, veterinary, and investigational medicinal products. Our quality control capabilities involve routine testing of biologic drugs, characterization of new biologics, and comparability studies to ensure each batch meets stringent safety standards for patient use.
Bioanalytical Services Across the Lifecycle
Understanding the behavior of biologics in the body necessitates advanced bioanalytical techniques. Our bioanalytical services include diverse methods for quantifying drugs, metabolites, and biomarkers in biological matrices, aiding studies from preclinical to post-market surveillance.
The reasons to choose Zenovel for biologic development:
- ·End-to-End Integration: We provide a seamlessly integrated development pathway that links discovery biology, regulatory strategy, GMP manufacturing support, and clinical execution, aiming to reduce fragmentation and speed up your program.
- · Deep Biologics Expertise: Our team of scientists and regulatory experts is well-versed in biologic drug development, guaranteeing that your project leverages the latest advancements and best practices in the industry.
- · Quality & Compliance at Every Stage: From research to commercial release, we prioritize quality, regulatory compliance, and patient safety.
- · Global Regulatory Alignment: We assist in navigating the complex global regulatory landscape, including CMC flexibilities for advanced therapies and rigorous data integrity and audit readiness expectations.
Zenovel offers comprehensive biology services to assist in the development of biologics from concept to therapy, emphasizing precision, foresight, and quality. We invite inquiries to expedite biologic development and facilitate access to innovations for patients.
Ready to accelerate your biologic development program? Contact Zenovel today.
